Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBR5-DT is an RNA gene located at the UBR5 genomic locus, designated as the "divergent transcript" due to its orientation and transcription relative to the main UBR5 gene. It is classified as a non-coding RNA (ncRNA) with no established protein product or well-defined biological functions, disease roles, or drug interactions. There is currently no evidence that UBR5-DT itself is a therapeutic target, nor is it recognized as a receptor, enzyme, transporter, or similar molecular entity. The query target "UBR5 divergent transcript" is not a canonical target molecule/receptor such as an enzyme or receptor protein. It is a non-coding RNA gene with undefined biological roles and is not considered a standard drug target. There are no data supporting "UBR5-DT" as a valid entry for molecular classification frameworks applied to therapeutic targets; it is therefore marked as "is_incorrect: true." If structured cataloging of therapeutic targets is intended, "UBR5-DT" should be excluded or noted as a non-target, and further clarification may be needed regarding any potential biological relevance or function, which remains unreported in current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBR5 divergent transcript (UBR5-DT).